StonvexLoading…
StonvexStonvexStonvexCore line items from OKTA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | $2.92B | $2.61B | $2.26B | $1.86B |
Operating Income | $149.00M | $-74.00M | $-516.00M | $-812.00M |
Net Income | $235.00M | $28.00M | $-355.00M | $-815.00M |
EPS (Diluted) | $1.31 | $0.06 | $-2.17 | $-5.16 |
Total Assets | $9.71B | $9.44B | $8.99B | $9.31B |
Total Liabilities | $2.71B | $3.03B | $3.10B | $3.84B |
Cash & Equivalents | $858.00M | $409.00M | $334.00M | $264.00M |
Free Cash Flow OCF − CapEx | $875.00M | $742.00M | $504.00M | $74.00M |
Shares Outstanding | 179.29M | 175.09M | 163.63M | 158.02M |